Premium
Novel regulation of melanogenesis by adiponectin via the AMPK / CRTC pathway
Author(s) -
Bang Seunghyun,
Won Kwang Hee,
Moon HyeRim,
Yoo Hanju,
Hong Areum,
Song Youngsup,
Chang Sung Eun
Publication year - 2017
Publication title -
pigment cell and melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12596
Subject(s) - ampk , microphthalmia associated transcription factor , adiponectin , protein kinase a , endocrinology , chemistry , creb , medicine , mediator , microbiology and biotechnology , signal transduction , activator (genetics) , adiponectin receptor 1 , adipokine , kinase , cancer research , biology , tyrosinase , transcription factor , biochemistry , receptor , leptin , diabetes mellitus , obesity , insulin resistance , gene , enzyme
Summary Several studies observed that adiponectin, an important adipokine that improves glucose metabolism by regulating AMP ‐activated protein kinase ( AMPK ) signaling, is dermatologically beneficial. In our recent microarray data, we found that adiponectin expression was lower in lesional skin than in non‐lesional skin of melasma patients. Given that AMPK is a key adiponectin signaling mediator, we investigated the role of adiponectin and AICAR , a cell‐permeable AMPK activator, in melanogenesis. We herein showed that adiponectin and AICAR downregulated MITF , tyrosinase, TRP ‐1, and DCT expression and reduced melanin content in normal human and mouse melanocytes. The depigmenting effect of adiponectin was mediated via AMPK activation, which induced the inhibitory phosphorylation of CREB ‐regulated transcription co‐activators ( CRTC s) and subsequent suppression of the novel CRTC / CREB pathway in melanocytes. These findings suggest that adiponectin and its analogs are useful as a clinical strategy for treating hyperpigmentation disorders.